1-3 of 3
Péter Rajnics, PhD
Close
Sort by
Journal Articles

Real World Data on the Efficacy and Safety of Daratumumab in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Hematology Centers

Gergely Varga, PhD, Tamas Masszi, MD Prof., Péter Farkas, MD, Nikolett Wohner, PhD, Ágnes Bereczki, MD, Zita Borbenyi, MD, Árpád Szomor, MD PhD, Hussain Alizadeh, MD PhD DSc, Erika Szaleczky, PhD, Krisztina Wolf, MD, Tamás Schneider, MD PhD, Mark Plander, PhD, Tamás Szendrei, MD, László Váróczy, MD PhD, Árpád Illés, Ottó Csacsovszky, MD, Zoltán Csukly, MD, Miklos Egyed, MD PhD, Péter Rajnics, PhD, Nora Adamkovich, MD, Szabolcs Kosztolányi, MD, Gábor Mikala, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3257.
https://doi.org/10.1182/blood-2018-99-115039
Published: 2018
Journal Articles

New Pulmonary Embolism Diagnostic Algorythm and the Thromboprophylaxis in a Hungarian Teaching Hospital.

Miklos Egyed, PhD, Peter Zadori, Peter Rajnics, PhD, Csaba Varga, Anita Horvath, Gyula Horvath, PhD
Journal: Blood
Blood (2007) 110 (11): 4000.
https://doi.org/10.1182/blood.V110.11.4000.4000
Published: 2007
Journal Articles

Fifth Succesfully Retreatment with Alemtuzumab in Patient with Chronic Lymphocytic Leukemia.

Miklos Egyed, PhD, Balazs Kollar, Eva Karadi, Peter Rajnics, PhD, Tamas Magyarlaki, PhD, Laszlo Kereskai, PhD
Journal: Blood
Blood (2007) 110 (11): 4713.
https://doi.org/10.1182/blood.V110.11.4713.4713
Published: 2007